Tanya Bhavnani is a Senior Director of Portfolio Strategy & Marketing at Arcus Biosciences, where she works on commercial strategy for the company's Immuno-Oncology portfolio, organizational launch readiness, and partnership execution with Gilead Sciences. Her career has been focused on launching therapeutics at Boehringer-Ingelheim, Pharmacyclics (an Abbvie Company), Dermira (acquired by Eli Lilly) as well as biotech investment banking at BTIG. She holds an M.S. in Biotechnology & Management and Bachelor's degrees in Biological Sciences and Business Administration from Carnegie Mellon University.